Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Moderna Inc (NASDAQ:MRNA) turned sharply lower Friday following reports that the Food and Drug Administration is delaying a decision on authorizing the company's COVID-19 vaccine for adolescents. The delay will give the FDA time to assess if ther vaccine could help lead to a heightened risk of a rare inflammatory heart condition called myocarditis.
Short Hills Capital's Steve Weiss thinks the pullback in Moderna shares is a buying opportunity, he said Friday on CNBC.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Weiss said the cases in which people developed myocarditis following vaccination all resulted in recovery from the heart condition.
"So I think there's really nothing there and that this is momentary and that it will come back," he said.
Moderna is much more effective than Pfizer Inc's (NYSE:PFE) vaccine based on the results of a study showing efficacy of the vaccines after six months, Weiss said. He stressed the news that investors should focus on is the approval of Moderna's booster, which was unanimously passed by the FDA’s Vaccines and Related Biological Products Advisory Committee on Thursday.
The booster is half the dose of the first two shots (50 micrograms instead of 100 micrograms) and the company estimates that the booster at the 50 microgram dose level could result in up to one billion additional doses.
"I think this is an opportunity to get in front of it and to buy it because I also expect mix and match to be approved later on today when the panel votes," Weiss said.
“Mix and match” refers to giving a different vaccine dose than the vaccine type that was used for the initial vaccination.
MRNA Price Action: Moderna has traded as high as $497.49 and as low as $65.48 over a 52-week period.
The stock was down 3.40% at $320.60 at time of publication.
Photo: Mufid Majnun from Pixabay.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.